Sign in

jpmkane.bsky.social

@jpmkane.bsky.social
189 followers 146 following 25 posts
PostsRepliesMedia
jpmkane.bsky.social @jpmkane.bsky.social · 15/09/2025
Passionate about neuroscience? 🧠 We’re recruiting a PhD student to join INSPECT-DLB - improving the diagnosis of dementia with Lewy bodies. Work at QUB with @ecebayram.bsky.social, Dr Claire McEvoy, me & team on this @lewybodysociety.bsky.social-funded project. 🔗 tinyurl.com/yck7466a
findaphd.com
Investigating the specificity and primary predictive value of the clinical diagnostic criteria for dementia with Lewy bodies (DLB) (InSpecT-DLB) at Queen’s University Belfast on FindAPhD.com
PhD Project - Investigating the specificity and primary predictive value of the clinical diagnostic criteria for dementia with Lewy bodies (DLB) (InSpecT-DLB) at Queen’s University Belfast, listed on ...
011
jpmkane.bsky.social @jpmkane.bsky.social · 17/07/2025
We are counting down for #AAIC25 and to catch up with our #LBDPIA members in person 😍 As we wait patiently, we prepared a webpage for you to find us, check out our work and join our team: sites.google.com/view/lbdpia-...
010
jpmkane.bsky.social @jpmkane.bsky.social · 14/07/2025
🎓 Are you an early-career researcher in #LewyBodyDementia? Join us at Lewy Connect, hosted by LBDA at #AAIC2025! 🗓️ July 29, 6–8pm 📍 InterContinental Toronto Centre 🔗 Network, meet LBD leaders, build your career! RSVP now—space is limited! 👇 doodle.com/sign-up-shee...
doodle.com
Doodle
Doodle is the simplest way to schedule meetings with clients, colleagues, or friends. Find the best time for one-to-ones and team meetings with our user-friendly calendar tool. Get started today!
020
jpmkane.bsky.social @jpmkane.bsky.social · 27/05/2025
There’s a lot of DLB research happening, but what are we actually asking people with DLB and their care partners? Which perspectives are we missing? @qubelfastofficial.bsky.social PhD candidate Paula Sinéad Donnelly leads this insightful scoping review👇 alzres.biomedcentral.com/articles/10....
alzres.biomedcentral.com
Research on the perspectives of people affected by dementia with Lewy bodies: a scoping review - Alzheimer's Research & Therapy
Background Dementia with Lewy bodies (DLB) is associated with specific challenges, including heterogeneity in clinical presentation and a less favourable prognosis relative to other dementia subtypes....
000
jpmkane.bsky.social @jpmkane.bsky.social · 27/05/2025
Last week @qubelfastofficial.bsky.social we were delighted to host Dr Yuto Satake from Osaka University and @ucl.ac.uk to discuss his work on AD & DLB biomarkers, very late onset psychosis and tackling loneliness with SoTa the robot. Come back soon Yuto!
010
jpmkane.bsky.social @jpmkane.bsky.social · 12/05/2025
We were joined today by attendees from FORTY-SIX countries! 🇦🇫 🇦🇽 🇩🇿 🇦🇴 🇦🇷 🇦🇿 🇧🇷 🇧🇳 🇧🇫 🇨🇦 🇨🇱 🇨🇳 🇨🇴 🇨🇿 🇪🇬 🇬🇪 🇩🇪 🇬🇭 🇬🇷 🇭🇰 🇮🇳 🇮🇩 🇮🇪 🇰🇪 🇲🇹 🇲🇺 🇲🇲 🇳🇬 🇵🇰 🇵🇪 🇵🇭 🇸🇦 🇸🇬 🇿🇦 🇪🇸 🇱🇰 🇸🇪 🇹🇼 🇹🇭 🇹🇹 🇹🇳 🇹🇷 🇬🇧 🇺🇸 🇻🇪 🇻🇳
021
Reposted by @jpmkane.bsky.social
Ece Bayram @ecebayram.bsky.social · 08/04/2025
📢📢 @istaart.bsky.social #DemenciaConCuerposDeLewy Seminario de Casos Clínicos en español tendrá lugar el 13 de mayo,10am US CT📢📢 #LBDPIA vicepresidente @frodriguezporcel.bsky.social moderará con oradores fabulosos Ceci Fernandez,Ruth Agnew&Fernando Garcia Regístrate! alz-org.zoom.us/webinar/regi...
032
jpmkane.bsky.social @jpmkane.bsky.social · 12/05/2025
Fantastic to host today's @istaart.bsky.social #LBDPIA Clinical Case Review webinar, with presentations from Dra. Cecilia Fernández & Drs Agnew, Garcia & Barton from @belfasttrust.bsky.social. Tomorrow's webinar will discuss the same cases in Spanish - register here istaart.alz.org/events/item/...
screenshot of a zoom webinar with five doctors speaking
043
jpmkane.bsky.social @jpmkane.bsky.social · 12/05/2025
Genial haber sido anfitrión del seminario web de Revisión de Casos Clínicos @istaart.bsky.social #LBDPIA de hoy con Dra. Cecilia Fernández y Drs. Agnew, Garcia y Barton de @belfasttrust.bsky.social. Regístrate aquí para nuestro seminario web en español mañana: istaart.alz.org/events/item/...
010
Reposted by @jpmkane.bsky.social
Lincoln Michel @thelincoln.bsky.social · 25/02/2025
Don't let anyone tell you that you can't live your dreams
News article with this passage highlighted: "who asked not to be identified because she has always wanted to be an anonymous source"
11640288
Reposted by @jpmkane.bsky.social
ISTAART @istaart.bsky.social · 23/01/2025
ISTAART is on Bluesky! Follow us as we discuss the latest in research and treatment and make connections to grow the global dementia science community.
0117
jpmkane.bsky.social @jpmkane.bsky.social · 05/12/2024
#AAIC25 is Canada-bound 🇨🇦 Abstract and session proposals can now be submitted at aaic.alz.org
This is a flyer for AAIC25 in Toronto. "Put a spotlight on your research" - abstract and session proposals due Jan 27th at alz.org/AAIC2025
000
jpmkane.bsky.social @jpmkane.bsky.social · 17/11/2024
@kaanthanj.bsky.social the profile pic 😂😂😂
110
jpmkane.bsky.social @jpmkane.bsky.social · 17/11/2024
@carlaabdelnour.bsky.social bienvenida Carla!
110
jpmkane.bsky.social @jpmkane.bsky.social · 17/11/2024
@rikossenkoppele.bsky.social welcome Rik!
010
jpmkane.bsky.social @jpmkane.bsky.social · 14/11/2024
“Well, here we all are now, all the lads”.
020
jpmkane.bsky.social @jpmkane.bsky.social · 14/11/2024
EU medicines agency has revised its initial verdict on lecanemab in (non ApoE4 homozygous) Alzheimer’s disease - recommending authorisation to EU bodies www.ema.europa.eu/en/news/leqe...
ema.europa.eu
Leqembi recommended for treatment of early Alzheimer’s disease | European Medicines Agency (EMA)
Re-examination concludes that benefits outweigh risks in a restricted patient population
010
jpmkane.bsky.social @jpmkane.bsky.social · 13/11/2024
A summary of EPIC training.
Bill MurrayAFC Bournemouth's Philip BillingBuffalo Bills Logo
000
jpmkane.bsky.social @jpmkane.bsky.social · 05/09/2024
"This must be the place", LP cover by Talking heads, depicting hands elbows and knees on a blue background
010